May 24, 2022
PAR-22-106 - Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The purpose of this Notice is to correct the Key Dates in Funding Opportunity Announcement (FOA) PAR-22-106, Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed).
Part 1. Overview Information, Key Dates
Currently reads:
|
Application Due Dates |
Review and Award Cycles |
||||
|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
|
June 16, 2022 * |
July 16, 2022 * |
September 07, 2022 * |
November 2022 |
January 2023 |
April 2023 |
|
October 16, 2022 * |
November 16, 2022 * |
January 07, 2023 * |
March 2023 |
May 2023 |
July 2023 |
|
February 16, 2023 * |
March 16, 2023 * |
May 07, 2023 * |
July 2023 |
October 2023 |
December 2023 |
|
June 16, 2023 * |
July 16, 2023 * |
September 07, 2023 * |
November 2023 |
January 2024 |
April 2024 |
|
October 16, 2023 * |
November 16, 2023 * |
January 07, 2024 * |
March 2024 |
May 2024 |
July 2024 |
|
February 16, 2024 * |
March 16, 2024 * |
May 07, 2024 * |
July 2024 |
October 2024 |
December 2024 |
|
June 16, 2024 * |
July 16, 2024 * |
September 07, 2024 * |
November 2024 |
January 2025 |
April 2025 |
|
February 16, 2025 * |
March 16, 2025 * |
May 07, 2025 * |
July 2025 |
October 2025 |
December 2025 |
|
June 16, 2025 * |
July 16, 2025 * |
September 07, 2025 * |
November 2025 |
January 2026 |
April 2026 |
Expiration Date: September 08, 2025
Corrected to read (in bold italics):
|
Application Due Dates |
Review and Award Cycles |
||||
|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
|
June 16, 2022 * |
July 16, 2022 * |
September 07, 2022 * |
November 2022 |
January 2023 |
April 2023 |
|
October 16, 2022 * |
November 16, 2022 * |
January 07, 2023 * |
March 2023 |
May 2023 |
July 2023 |
|
February 16, 2023 * |
March 16, 2023 * |
May 07, 2023 * |
July 2023 |
October 2023 |
December 2023 |
|
June 16, 2023 * |
July 16, 2023 * |
September 07, 2023 * |
November 2023 |
January 2024 |
April 2024 |
|
October 16, 2023 * |
November 16, 2023 * |
January 07, 2024 * |
March 2024 |
May 2024 |
July 2024 |
|
February 16, 2024 * |
March 16, 2024 * |
May 07, 2024 * |
July 2024 |
October 2024 |
December 2024 |
|
June 16, 2024 * |
July 16, 2024 * |
September 07, 2024 * |
November 2024 |
January 2025 |
April 2025 |
|
October 16, 2024 * |
November 16, 2024 * |
January 07, 2025 * |
March 2025 |
May 2025 |
July 2025 |
|
February 16, 2025 * |
March 16, 2025 * |
May 07, 2025 * |
July 2025 |
October 2025 |
December 2025 |
Expiration Date: May 08, 2025
All other aspects of this FOA remain unchanged.
Gila Neta, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6785
Email: Gila.Neta@nih.gov
and Human Services (HHS)
